Ortiz De Landazuri, I., Oliver-Caldés, A., Español-Rego, M., Contreras, M. T., Zabaleta, A., Agulló, C., Puig, N., Cabañas, V., González-Calle, V., Jiménez, R., Inogés, S., Rodríguez-Otero, P., Martin-Antonio, B., Reguera, J. L., López-Diaz de Cerio, A., Benítez-Ribas, D., Rodríguez-Lobato, L. G., González, E. A., Rosiñol, L., Yagüe, J., Moraleda, J. M., Urbano-Ispizua, Á., Mateos, M. V., Juan, M., Paiva, B., Pascal, M., & Fernández de Larrea, C. (n.d.). p862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY. HemaSphere, 6, 755–756. http://access.bl.uk/ark:/81055/vdc_100159756831.0x00000f